ORENCIA(R) (abatacept) or REMICADE(R)(infliximab) Demonstrated Superior Efficacy to Placebo at Six Months With ORENCIA Demonstrating Both Durable Efficacy and a More Favorable Safety Profile Through 12 Months
15th Nov 2006, 03:38 GMT
ORENCIA(R) (abatacept) or REMICADE(R)(infliximab) Demonstrated Superior Efficacy to Placebo at Six Months With ORENCIA Demonstrating Both Durable Efficacy and a More Favorable Safety Profile Through 12 Months related news:
- ORENCIA(R) (abatacept) Data Demonstrated Improvement In Children And Adolescents With Juvenile Idiopathic Arthritis — Health News from Medical News Today
- Volume 194, number 12: Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV-1 Vaccine among Injection Drug Users in Bangkok, Thailand — J Infect Dis Latest Issue
- Amgen arthritis drug shows sustained safety and efficacy — Pharmaceutical Business Review Latest News
- Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data — EurekAlert! - Medicine and Health
- ORENCIA Data Demonstrated Improvement in Children and Adolescents With Juvenile Idiopathic Arthritis as Measured by the Validated ACR Pediatric Criteria — StratWire - Business of Healthcare NewsFeed
- New Surgeon-In-Chief Adapts Airline Safety Program To Improve Patient Safety — Health News from Medical News Today
- The Elevator Escalator Safety Foundation: The Elevator Escalator Safety Foundation Celebrates National Elevator Escalator Safety Awareness Week — Market Wire - Government
- Complementary Medicine Has A Role In The Treatment Of Allergic Diseases — Health News from Medical News Today
- The Elevator Escalator Safety Foundation Celebrates National Elevator Escalator Safety Awareness Week — ArriveNet : Press Releases
- Interim Analysis of New Study Suggests Boosted INVIRASE May Achieve Similar Levels of HIV Suppression to Boosted Lopinavir with a Favorable Lipid Profile — Pharmaceuticals News from StratCenter.com
Latest news from PR Newswire: All Releases:
- AXA Announces the Successful Completion of Its First Mortality Risk Securitization Transaction
- "Powder Coatings in Europe 2005/2006-2016 - A New Dawn" Plus a General Overview of the Powder Coatings Markets in the Middle East & Africa
- Tech Industry Innovator Fred Greenberg Joins Veridigm's Board of Directors
- SST Sets New Benchmark With Industry's First 1.8V Ultra Low Power, Ultra Thin SPI Serial Flash Memory Family
- Esaote Harnesses Texas Instruments DSPs to Deliver Next-Generation Medical Diagnostic Systems
- QUALCOMM and Motorola to Collaborate on UMTS Handsets
- SIA Lattelecom Steps up Volumes With Carrier Cockpit(TM)
- Exciting Times for Laboratory Information Systems in the Era of the Electronic Medical Record
- Belgium Cable Investors Exercises Options to Increase Stake in Telenet Group Holding N.V.
- Mercer Survey Finds That Organizations in Greater China Fail to Identify Critical Jobs and Fall Short in Career Development